| View |
|
DR-XY34746
|
Sodium Alginate+ Sodium Bicarbonate + Calcium Carbonate
|
Gaviscon
|
500 mg/267 mg/160 mg per 10 mL
|
Oral Suspension
|
Antacid
|
Reckitt Benckiser Healthcare (UK) Limited
|
United Kingdom
|
Automatic Renewal
|
11 February 2023
|
25 July 2028
|
| View |
|
DR-XY34755
|
Erythromycin (as ethylsuccinate)
|
Erycar
|
100mg/2.5mL
|
Granules For Suspension (Oral Drops)
|
Antibacterial (Macrolide)
|
Ace Pharmaceuticals, Inc.
|
Philippines
|
Renewal
|
04 August 2023
|
30 July 2028
|
| View |
|
DR-XY34756
|
Cephradine
|
Zolicef
|
500 mg
|
Powder For Injection
|
Antibacterial (Cephalosporin)
|
Harbin Pharmaceutical Group Co., Ltd. General Pharm. Factory
|
China
|
Automatic Renewal
|
28 June 2023
|
30 July 2028
|
| View |
|
DR-XY34761
|
Perindopril Erbumine
|
Perigard-2
|
2 mg
|
Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
Glenmark Pharmaceuticals Ltd.
|
India
|
Automatic Renewal
|
06 March 2023
|
30 July 2028
|
| View |
|
DR-XY34774
|
Iron Sucrose
|
Ferrofer
|
20 mg/mL
|
Solution For Injection (Iv)
|
-
|
Nanjing Hencer Pharmaceutical Co., Ltd.
|
China
|
-
|
18 August 2020
|
06 August 2025
|
| View |
|
DR-XY34776
|
Co-Amoxiclav
|
Natravox
|
228.5 mg per 5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
31 January 2023
|
11 August 2028
|
| View |
|
DR-XY34777
|
Co-Amoxiclav
|
Natravox
|
400mg/57mg per 5mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 March 2023
|
11 August 2028
|
| View |
|
DR-XY34778
|
Co-Amoxiclav
|
Natravox
|
250mg/62.5mg per 5mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
06 March 2023
|
11 August 2028
|
| View |
|
DR-XY34785
|
Co-Amoxiclav
|
Natravox
|
125mg/31.25mg per 5mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
31 January 2023
|
12 August 2028
|
| View |
|
DR-XY34788
|
Sevoflurane
|
None
|
100% w/w
|
Volatile Liquid for Inhalation
|
General Anesthetic
|
Baxter Healthcare of Puerto Rico
|
U.S.A.
|
Automatic Renewal
|
20 July 2023
|
12 August 2028
|
| View |
|
DR-XY34795
|
Clindamycin (As Hydrochloride)
|
Indanox
|
300 mg
|
Capsule
|
-
|
PT Guardian Pharmatama
|
Indonesia
|
Renewal
|
28 January 2022
|
13 August 2026
|
| View |
|
DR-XY34797
|
Clindamycin (as phosphate)
|
None
|
10 mg/mL (1%)
|
Topical Solution
|
Antibacterial (Anti-acne)
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Initial (Variation)
|
06 March 2024
|
06 March 2029
|
| View |
|
DR-XY34800
|
Quinapril Hydrochloride
|
Quinapro
|
20 mg
|
Film-Coated Tablet
|
Angiotensin Converting Enzyme (ACE) Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 August 2023
|
13 August 2028
|
| View |
|
DR-XY34809
|
Paracetamol + Tramadol Hydrochloride
|
Algesia
|
37.5 mg/325 mg
|
Tablet
|
Antipyretic / Opioid Analgesic
|
Amherst Laboratories Inc.
|
Philippines
|
Renewal
|
14 August 2018
|
15 August 2028
|
| View |
|
DR-XY34825
|
Cinnarizine
|
Stugeron
|
25 mg
|
Tablet
|
Anti-vertigo
|
Janssen Korea Ltd.
|
Korea
|
Automatic Renewal
|
08 July 2023
|
20 August 2028
|
| View |
|
DR-XY34826
|
Zinc (as Sulfate Monohydrate)
|
Biozinc
|
20 mg per 5 mL 55 mg per 5 mL
|
Syrup
|
Mineral
|
Sydenham Laboratories, Inc.
|
Philippines
|
Renewal
|
31 October 2018
|
20 August 2028
|
| View |
|
DR-XY34840
|
Betahistine Hydrochloride
|
Vert
|
8 mg
|
Film-Coated Tablet
|
Anti-Vertigo Preparations
|
Lloyd Laboratories,Inc.
|
Philippines
|
Renewal
|
21 March 2023
|
22 August 2028
|
| View |
|
DR-XY34842
|
Co-Amoxiclav
|
Cavumox
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Siam Bheasach Co. Ltd
|
Thailand
|
Renewal
|
22 November 2023
|
20 January 2029
|
| View |
|
DR-XY34843
|
Co-Amoxiclav
|
Cavumox
|
1 g
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Siam Bheasach Co. Ltd
|
Thailand
|
Renewal
|
07 December 2023
|
20 January 2029
|
| View |
|
DR-XY34848
|
Fluticasone Propionate
|
Nasoflo
|
50 mcg
|
Aqueous Nasal Spray
|
Nasal Corticosteroid
|
Square Pharmaceuticals Ltd.
|
Bangladesh
|
Automatic Renewal
|
22 July 2023
|
28 August 2028
|